Angina Newswire

Angina Newswire

Comprehensive Real-Time News Feed for Angina.

Results 1 - 20 of 155 in Angina

  1. Fibrates May Be Better Option Than Statins for SomeRead the original story w/Photo

    Yesterday | The News-Review

    ... review analysis of 18 studies involving more than 45,000 patients showed a 13 percent decrease in heart attacks and angina among people who were taking fibrates, but no reduction in stroke risk, no decrease in overall death rates and no decrease in ...

    Comment?

  2. Gastrointestinal Electrocardiograph Market Estimated to Flourish by...Read the original story w/Photo

    Wednesday Feb 22 | SBWire

    ... abdominal distension, vomiting, nausea, diarrhea and constipation. It is difficult to differentiate the symptoms of angina pectoris and gastro-esophageal problems. Diseases related to cardiac and gastrointestinal diseases are complex. The ...

    Comment?

  3. Flintshire Council pushing ahead with plans to dispose of danger chemicals siteRead the original story w/Photo

    Wednesday Feb 22 | Flintshire Standard

    Flintshire Council's cabinet agreed that the former Euticals site in Sandycroft, where potentially dangerous chemicals and caustic acid were left at the base when the company went into liquidation in July 2013, should be disposed of. Neal Cockerton, the council's chief officer for organisational change, said: "The former Euticals site, located at Prince William Avenue in Sandycroft, was used for the processing of chemicals, most notably Isosorbide Dinitrate a drug used for the treatment of angina.

    Comment?

  4. Options for adults with ADHDRead the original story w/Photo

    Tuesday Feb 21 | Weirton Daily Times

    ... (I take half of a 600-mg capsule of powdered magnesium malate in a little water before going to bed.) I also have angina and take diltiazem and sometimes nitroglycerine. Will the magnesium have a negative effect on my heart problem? If not, can I ...

    Comment?

  5. Why President Trump Should Buy Gilead SciencesRead the original story w/Photo

    Friday Feb 17 | The Motley Fool

    ... rates in the company's HIV franchise (sales up 12% in Q4), in hypertension drugs (Letairis sales up 15%), and in angina treatment (Ranexa sales up 24%). But the success of these businesses hasn't been enough to distract from Gilead's HCV business, ...

    Comment?

  6. Management of Coronary Artery Disease and Chronic Stable AnginaRead the original story w/Photo

    Thursday Feb 16 | US Pharmacist

    ABSTRACT: Coronary artery disease is the most common type of heart disease and the leading cause of death worldwide. Angina pectoris , a clinical syndrome characterized by discomfort typically located in the chest, neck, or left arm, is one of several clinical manifestations of CAD.

    Comment?

  7. Prognostic Impact of Coronary Vasodilator Dysfunction on Adverse...Read the original story

    Apr 25, 2000 | Circulation

    ... blood flow, and dilation in response to nitroglycerin. Cardiovascular events (cardiovascular death, unstable angina, myocardial infarction, percutaneous transluminal coronary angioplasty, coronary bypass grafting, ischemic stroke, or peripheral ...

    Comment?

  8. Long-Term Follow-Up of Patients With Mild Coronary Artery Disease and Endothelial DysfunctionRead the original story

    Mar 7, 2000 | Circulation

    ... Exclusion criteria included history of myocardial infarction, percutaneous coronary revascularization, CABG, unstable angina pectoris, history of variant angina, uncontrolled hypertension, peripheral vascular disease, ejection fraction a< 50%, and ...

    Comment?

  9. How to Image Cardiac AmyloidosisRead the original story

    May 1, 2014 | Circulation

    ... mild ankle edema. He was previously fit but was now breathless on climbing 2 flights of stairs. He had no history of angina, orthopnea, or paroxysmal nocturnal dyspnea. His medical history included non-insulin-dependent diabetes mellitus treated for ...

    Comment?

  10. 5 Things Gilead Sciences' Management Said as Its Stock SlumpedRead the original story w/Photo

    Wednesday Feb 8 | Fox News

    ... forpulmonary arterial hypertension drug Letairis expires in 2018. A year later, Gilead loses patent protection for angina drug Ranexa. Milligan said that these looming patent losses "puts some downward pressure" on its non-HCV revenue. However, he ...

    Comment?

  11. Gilead Sciences Inc. Reports Q4 Earnings Decline and Worsening Outlook for 2017Read the original story w/Photo

    Tuesday Feb 7 | Fox News

    ... sales forpulmonary arterial hypertension drug Letairis increased 15% year over year, to $226 million. Sales for angina treatment Ranexa jumped 24%, to $210 million. Gilead's outlook for 2017 was the most disturbing thing in its update. The company ...

    Comment?

  12. Taxus Cardium Release: FDA Grants Fast Track Designation To...Read the original story

    Monday Feb 6 | BioSpace

    Taxus Cardium Release: FDA Grants Fast Track Designation To Angionetics' Generx Product Candidate, A One-Time Gene Therapy For Coronary Heart Disease /PRNewswire/ -- Angionetics Inc., a majority-owned subsidiary of Taxus Cardium Pharmaceuticals Group Inc. , today reported that the FDA has granted Fast Track designation for the Phase 3 clinical investigation of Generx [Ad5FGF-4] cardiovascular angiogenic gene therapy as a one-time treatment for improving exercise tolerance in patients who have angina that is refractory to standard medical therapy and not amenable to conventional revascularization procedures . For more information please visit www.angionetics.com and www.MyRefractoryAngina.com .

    Comment?

  13. Amgen's Cholesterol-Lowering Drug Repatha Wows in Huge Heart StudyRead the original story

    Thursday Feb 2 | BioSpace

    Amgen Announces RepathaA Significantly Reduced The Risk Of Cardiovascular Events In FOURIER Outcomes Study - Landmark Repatha Cardiovascular Outcomes Study Meets Primary and Key Secondary Endpoint - Detailed Results to be Presented at ACC 66th Annual Scientific Session /PRNewswire/ -- Amgen today announced that the FOURIER trial evaluating whether RepathaA reduces the risk of cardiovascular events in patients with clinically evident atherosclerotic cardiovascular disease met its primary composite endpoint , non-fatal stroke, hospitalization for unstable angina or coronary revascularization) and the key secondary composite endpoint . No new safety issues were observed.

    Comment?

  14. CRP level key in assessing statin needRead the original story w/Photo

    Jan 27, 2017 | The Citizens' Voice

    ... shown benefit in reducing the risk of heart attacks and strokes in people who have had a previous heart attack or angina. This benefit is called secondary prevention. Statins have also shown benefit in people with risk factors for heart disease who ...

    Comment?

  15. CRP Level May Determine If Patient Needs StatinRead the original story w/Photo

    Jan 21, 2017 | The News-Review

    ... shown benefit in reducing the risk of heart attacks and strokes in people who have had a previous heart attack or angina. This benefit is called secondary prevention. Statins have also shown benefit in people with risk factors for heart disease who ...

    Comment?

  16. Best lla Piller Nifedipine 5 mg a " Safe & Secure orderhantering a " Snabb V rldsomsp nnande s ndningsRead the original story

    Jan 18, 2017 | Hernando Today

    ... ressure. For over 30 years, Adalat has been a leading name in calcium channel blockers made to treat hypertension and angina. When used effectively, Generic Adalat reduces the risk of heart attack and stroke by 50%!

    Comment?

  17. Letter: Grateful for NHS servicesRead the original story

    Jan 17, 2017 | Filey Today

    ... tests and observation, a second (equally pleasant) heart consultant had concluded that I had suffered the symptoms of angina (something caused through age-related hardening of the arteries, or clogging of same, and not always causing pain) and I ...

    Comment?

  18. Rx Product Profile: ByvalsonRead the original story

    Jan 17, 2017 | Pharmacy Times

    ... not be abruptly discontinued in patients with coronary artery disease, as this may lead to an acute exacerbation of angina, MI, or ventricular arrhythmias. Patients with diabetes should monitor their glucose carefully, as beta-blockers may mask the ...

    Comment?

  19. Keeping a healthy heartRead the original story

    Jan 16, 2017 | IcNetwork

    ... blood, become narrowed by a gradual build up of fatty material. The discomfort or pain from such narrowing is called angina and if a blockage occurs it can cause a heart attack. It is the leading cause of death worldwide and Wales's single biggest ...

    Comment?

  20. Acheter Adalat En Ligne A Prix Reduit a " Exp dition trackable a " Livraison RapideRead the original story

    Jan 15, 2017 | Hernando Today

    ... For over 30 years, Adalat has been a leading name in calcium channel blockers made to treat hypertension and angina. When used effectively, Generic Adalat reduces the risk of heart attack and stroke by 50%! Generic Adalat may also be marketed as: ...

    Comment?